Snap-8 is a synthetically engineered octapeptide (Ac‑Glu‑Glu‑Met‑Gln‑Arg‑Arg‑Ala‑Asp‑NH₂) that mimics the N‑terminal region of SNAP‑25, a key component of the neuronal SNARE complex. Because it interacts with the same protein interface, researchers use the Snap-8 research peptide to explore vesicle fusion mechanisms, signal transduction pathways, and peptide‑protein binding dynamics in controlled laboratory settings. The compound is supplied with full analytical documentation, third‑party testing, and a Certificate of Analysis, ensuring that it meets the high‑purity standards required for reproducible scientific work. All material is provided for research use only and is not intended for human or animal consumption.
Research Background
Snap‑8 originated as an eight‑amino‑acid extension of the well‑known acetyl hexapeptide‑3 (Argireline). By adding two additional residues to the C‑terminus, Lipotec, a Spanish biotechnology firm, created a peptide that more closely resembles the native N‑terminus of SNAP‑25, thereby increasing its affinity for the SNARE protein complex. The sequence Ac‑Glu‑Glu‑Met‑Gln‑Arg‑Arg‑Ala‑Asp‑NH₂ was designed to probe the structural requirements for SNAP‑25 mediated exocytosis, offering a tool for in‑vitro assays that examine neurotransmitter release, hormone secretion, and other vesicular processes. Since its introduction, Snap‑8 has been incorporated into a range of biochemical and cell‑based studies, providing insight into the modulation of SNARE assembly, the kinetics of membrane fusion, and the design of selective peptide inhibitors. The peptide's high purity, GMP‑grade manufacturing, and transparent COA make it a preferred candidate for laboratories investigating SNARE‑related pathways.
Mechanism of Action
Snap-8 mimics the N‑terminal domain of SNAP‑25, a core component of the neuronal SNARE complex that drives vesicle docking and the calcium‑triggered release of catecholamines and other neurotransmitters. In the canonical SNARE assembly, SNAP‑25 contributes two helices that pair with the single helix of syntaxin‑1 on the plasma membrane and the helix of VAMP/synaptobrevin on the vesicle membrane, forming a tight four‑helix bundle. This bundle pulls the vesicle and plasma membranes together, creating the force required for membrane fusion. In vitro studies using recombinant proteins and lipid‑mixing assays indicate that the Snap-8 research peptide competitively occupies the binding groove normally engaged by SNAP‑25's N‑terminal segment, thereby destabilizing the early "trans‑SNARE" intermediate. By acting as a steric blocker, Snap‑8 reduces the efficiency of complex formation and attenuates downstream exocytotic events in cultured neuronal and adrenal chromaffin cell models. The peptide's acetylated N‑terminus supports its stability in aqueous assay conditions, allowing researchers to probe the kinetic steps of SNARE zippering with high specificity. All data are generated under controlled laboratory conditions and the product is supplied for research use only.
Published Research Overview
The literature on SNAP‑25 mimetic peptides, including acetyl‑octapeptide analogs, sits primarily within basic neuroscience and cosmetic‑science domains. Reports in the International Journal of Cosmetic Science and related titles have explored this class of peptide in the context of skin‑cell signaling pathways, while foundational work on SNARE‑mediated exocytosis published in journals such as Nature Reviews Molecular Cell Biology and the Journal of Biological Chemistry describes the molecular machinery that Snap‑8 is designed to probe. Across this body of work, investigators have employed the Snap-8 research peptide and related fragments to assess competitive inhibition of SNARE assembly, quantify changes in calcium‑evoked release of neurotransmitters, and evaluate downstream signaling cascades in cultured neurons and endocrine cells. Reported findings generally indicate that the peptide reduces the rate of SNARE complex formation in these models. Additional studies have examined structure‑activity relationships by comparing acetylated versus non‑acetylated variants, with N‑terminal acetylation associated with greater resistance to proteolysis in vitro. It should be noted that the peptide‑specific literature remains limited and largely pre‑clinical, and that much of the published cosmetic‑science work is manufacturer‑funded. All peptide batches are provided with full COA, GMP certification, and third‑party purity testing, intended solely for research use only.
Storage & Handling
Lyophilized Snap-8 should be stored sealed in an amber vial, protected from light and moisture, with long‑term storage at −20 °C in a desiccated environment. Avoid repeated freeze‑thaw cycles and repeated temperature cycling. Once reconstituted, keep the solution cold, use sterile low‑binding tubes, and label with peptide name, batch number, and date of preparation. Discard any material that shows precipitation or discoloration. Store labeled containers in a monitored freezer or refrigerator to maintain consistent temperature.
Conclusion
The Snap-8 research peptide is a tool for exploring peptide‑protein interactions and signal transduction pathways in vitro. Because experimental outcomes are sensitive to contaminant levels, confirming purity by HPLC and exact mass by LC‑MS is essential. Dynamite Research Peptides provides full COA documentation, GMP‑certified manufacturing, and third‑party testing to support batch‑to‑batch consistency. Reliable analytical data allow investigators to draw reproducible conclusions and to integrate the peptide into assay development and mechanistic studies with confidence.
Frequently Asked Questions
What is Snap-8?
Snap-8, also known as acetyl octapeptide‑3, is a synthetic octapeptide that mimics a fragment of the SNAP‑25 protein. It is used in laboratory studies to investigate protein–protein interactions and SNARE‑mediated signaling mechanisms.
How is the purity of Snap-8 verified?
Purity is confirmed through high‑performance liquid chromatography (HPLC) and mass spectrometry (LC‑MS). Third‑party Certificates of Analysis detail the chromatographic profile and exact mass, documenting that each batch meets its declared purity specification.
Is Snap-8 approved for human use?
No. Snap-8 is not approved for any clinical or consumer application. It is supplied strictly for laboratory research purposes and must not be used in humans or animals.
All products are for research use only — not for human or animal consumption.